
Aquavit Pharmaceuticals: Innovating personalized medicine and modern healthcare solutions.
Founded with a mission to revolutionize personalized medicine, Aquavit Pharmaceuticals focuses on discovering, developing, and commercializing innovative pharmaceuticals, medical devices, and health technologies. The company aims to enhance patient health and optimize medical community efficiency through a diverse approach that addresses significant unmet needs. Their product pipeline spans multiple specialties, including neuroscience, oncology, medical dermatology, medical aesthetics, and immunology (COVID-19).
Aquavit Pharmaceuticals has garnered attention for its pioneering work in personalized healthcare delivery systems. The company collaborates with leading experts and investors in the healthcare sector to drive its mission forward. Notable achievements include advancements in early-stage to commercialization phases across various medical fields. Aquavit's impact is evident in its commitment to modernizing healthcare and improving patient outcomes through cutting-edge solutions.

Alavita Pharmaceuticals
alavita.lu

Aria Pharmaceuticals

Navitor Pharmaceuticals

Manhattan Pharmaceuticals

Accuitis
accuitis.com

iQure Pharma
iqurepharma.com

Aquinnah Pharmaceuticals
aquinnahpharma.com

Auxilius Pharma
auxiliuspharma.com

Quark Pharmaceuticals

PIN Pharma
pinpharma.com

PleoPharma
pleopharma.com

Aviv Pharma

Iacta Pharmaceuticals

Aquestive Therapeutics
aquestive.com

Novita Pharmaceuticals
novita-pharm.com
Companies similar to Aquavit Pharmaceuticals include Alavita Pharmaceuticals, Aria Pharmaceuticals, Navitor Pharmaceuticals and Manhattan Pharmaceuticals.
Aquavit Pharmaceuticals was founded in 2010.
Aquavit Pharmaceuticals' headquarters is located in New York City, NY, US.
Aquavit Pharmaceuticals' most recent funding round was for $330k (USD) in December 2012.
As of Dec 30, 2012, Aquavit Pharmaceuticals has raised a total of $330k (USD).
Aquavit Pharmaceuticals has 15 employees as of Feb 4, 2024.